Genkyotex Invites Shareholders to Annual General Meeting on June 13, 2019
Documents related to AGM available on Genkyotex website or upon request Genkyotex advancing on strategy for further development of GKT831 in fibrotic liver diseases GKT831 Ph2 DKD trial progresses and Ph2 IPF trial launch upcoming ARCHAMPS, France, May 23, …